1. Home
  2. AZTR vs CREG Comparison

AZTR vs CREG Comparison

Compare AZTR & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • CREG
  • Stock Information
  • Founded
  • AZTR 2014
  • CREG N/A
  • Country
  • AZTR United States
  • CREG China
  • Employees
  • AZTR N/A
  • CREG N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • CREG Power Generation
  • Sector
  • AZTR Health Care
  • CREG Utilities
  • Exchange
  • AZTR Nasdaq
  • CREG Nasdaq
  • Market Cap
  • AZTR 4.2M
  • CREG 4.6M
  • IPO Year
  • AZTR 2023
  • CREG N/A
  • Fundamental
  • Price
  • AZTR $0.73
  • CREG $1.46
  • Analyst Decision
  • AZTR Strong Buy
  • CREG
  • Analyst Count
  • AZTR 1
  • CREG 0
  • Target Price
  • AZTR $4.00
  • CREG N/A
  • AVG Volume (30 Days)
  • AZTR 158.2K
  • CREG 385.3K
  • Earning Date
  • AZTR 11-11-2025
  • CREG 11-07-2025
  • Dividend Yield
  • AZTR N/A
  • CREG N/A
  • EPS Growth
  • AZTR N/A
  • CREG N/A
  • EPS
  • AZTR N/A
  • CREG N/A
  • Revenue
  • AZTR N/A
  • CREG $82,839.00
  • Revenue This Year
  • AZTR N/A
  • CREG N/A
  • Revenue Next Year
  • AZTR N/A
  • CREG N/A
  • P/E Ratio
  • AZTR N/A
  • CREG N/A
  • Revenue Growth
  • AZTR N/A
  • CREG N/A
  • 52 Week Low
  • AZTR $0.68
  • CREG $1.02
  • 52 Week High
  • AZTR $4.33
  • CREG $14.70
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 50.75
  • CREG 46.12
  • Support Level
  • AZTR $0.68
  • CREG $1.02
  • Resistance Level
  • AZTR $0.79
  • CREG $1.50
  • Average True Range (ATR)
  • AZTR 0.04
  • CREG 0.23
  • MACD
  • AZTR -0.02
  • CREG -0.04
  • Stochastic Oscillator
  • AZTR 40.21
  • CREG 35.68

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: